Provided by Tiger Trade Technology Pte. Ltd.

Eloxx Pharmaceuticals (Uplisting)

19.18
+2.1812.82%
Post-market: 19.180.00000.00%18:44 EDT
Volume:51.27K
Turnover:975.50K
Market Cap:77.42M
PE:-5.09
High:19.96
Open:18.39
Low:17.98
Close:17.00
52wk High:19.96
52wk Low:0.0000
Shares:4.04M
Float Shares:2.39M
Volume Ratio:1.17
T/O Rate:2.15%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.7716
EPS(LYR):-183.1293
ROE:-615.23%
ROA:-97.59%
PB:-10.21
PE(LYR):-0.10

Loading ...

Eloxx Rugi Bersih Q2 FY26 Melebar 138% Menjadi USD 4,5 Juta

Reuters
·
10 hours ago

Eloxx Pharmaceuticals Initiated at Outperform by Lifesci Capital

Dow Jones
·
Jul 23

Eloxx Pharmaceuticals initiated with an Outperform at LifeSci Capital

TIPRANKS
·
Jul 22

Eloxx Pharmaceuticals Initiated at Buy by Guggenheim

Dow Jones
·
Jul 20

U.S. Research Roundup- Anterix, Fidus Investment, Nextpower

Reuters
·
Jul 20

Eloxx Pharmaceuticals initiated with a Buy at Guggenheim

TIPRANKS
·
Jul 20

Eloxx Pharmaceuticals Inc trading halted, volatility trading pause

TIPRANKS
·
Jul 09

NASDAQ Trade Halt Volatility Trading Pause at 11:17 Am

Reuters
·
Jul 09

Eloxx’s EXACT Study Puts Exaluren in Focus for Rare Kidney Disease Investors

TIPRANKS
·
Jul 02

Eloxx Pharmaceuticals initial beneficial ownership filing names Domicilium Real Estate Fund III LP as 10% owner

Reuters
·
Jun 18

Eloxx Pharmaceuticals Inc trading halted, volatility trading pause

TIPRANKS
·
Jun 17

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 02:19 PM

Reuters
·
Jun 17

Eloxx Pharmaceuticals Inc trading halted, volatility trading pause

TIPRANKS
·
Jun 11

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:30 AM

Reuters
·
Jun 10

NASDAQ TRADE HALT REASON NOT AVAILABLE AT 04:00 AM

Reuters
·
Jun 09

Eloxx Pharmaceuticals files Form 3 for director Nina S. Kjellson, reporting no beneficial ownership

Reuters
·
Jun 01

Eloxx Pharma shareholders back reverse stock split of up to 1-for-20

Reuters
·
May 09

Eloxx Pharmaceuticals Inc - Applies to List Common Stock on Nasdaq Under Symbol Elox - SEC Filing

THOMSON REUTERS
·
May 08

Eloxx Q1 net loss widens to $3.75 million; operating loss widens to $3.8 million

Reuters
·
May 05

Eloxx Pharmaceuticals sees Domicilium Real Estate Fund III LP file initial beneficial ownership statement

Reuters
·
May 05